Robert obtained his PhD at the University of Reading, UK with his thesis specialising on the regenerative capabilities of the adult stem cell secretome, with a particular emphasis on its effect on skeletal muscle. Robert is a co-founder of Micregen and currently Director of R&D. Since 2019 Robert has managed and coordinated Micregen’s clinical manufacturing programme, preparing Micregen’s first therapeutic to enter a combined phase I/II clinical trial in the UK.
Meet peers and build meaningful connections with experts and industry leaders.
Learn from speakers through scientific sessions, keynotes, and practical workshops.
Capture insights to shape your research, roadmap, and future collaborations.
Grow your impact by sharing work and engaging with the global community.